Author： Berstein L. Kvatchevskaya J. Poroshina T. Kovalenko I. Tsyrlina E. Zimarina T. Ourmantcheeva A. Ashrafian L. Thijssen J.
Publisher： Springer Publishing Company
ISSN： 0171-5216
Source： Journal of Cancer Research and Clinical Oncology, Vol.130, Iss.11, 2004-11, pp. : 687-693
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Related content
Clinical disease course during the last year in ovarian cancer
By von Gruenigen V.E. Frasure H.E. Reidy A.M. Gil K.M.
Gynecologic Oncology, Vol. 90, Iss. 3, 2003-09 ,pp. :
Access to resources
Recommend
By Tecimer C. Doering D.L. Goldsmith L.J. Meyer J.S. Abdulhay G. Wittliff J.L.
Gynecologic Oncology, Vol. 80, Iss. 1, 2001-01 ,pp. :
Expression and clinical significance of FXYD3 in endometrial cancer
Oncology Letters, Vol. 8, Iss. 2, 2014-01 ,pp. :
Biomarkers in endometrial cancer: Possible clinical applications (Review)
Oncology Letters, Vol. 3, Iss. 6, 2012-01 ,pp. :